MedTrace Logo

Amantadine to Speed Awakening After Cardiac Arrest

NCT02486211 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2019-12-04

Study results available
· View outcomes & findings →

Summary

This study evaluates if amantadine will increase the rate of awakening in patients resuscitated from cardiac arrest but comatose (not following commands) after their resuscitation. Half of the participants will receive amantadine and the other will receive placebo.

Conditions

  • Coma
  • Heart Arrest
  • Anoxia

Interventions

DRUG

Amantadine

100mg twice per day for 7 days at 0600 and 1200

DRUG

Placebo

Placebo comparator

Sponsors & Collaborators

Principal Investigators

  • Jon C Rittenberger, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02486211 on ClinicalTrials.gov